Radiesse 1.5ml

Radiesse 1.5ml is an advanced dermal filler created for structural correction and restoring volume. This injectable dermal filler contains synthetic calcium hydroxyapatite caha in an aqueous gel and comes in a pre filled syringe for professional use. It is intended for correction of moderate to severe facial wrinkles and folds, including nasolabial folds, and provides immediate volume at placement. The formula also supports longer-term tissue changes through collagen stimulation.

Characteristics of Radiesse 1.5ml

The formula contains CaHA microspheres suspended in sterile water, glycerin, and sodium carboxymethylcellulose. In this formulation, the merz pharma active substance is synthetic calcium hydroxyapatite (CaHA). The Radiesse gel carrier produces the initial filling effect, while the microspheres support the body’s natural collagen production. CaHA is completely biodegradable over time rather than a permanent implant.

Key product details are:

• 1.5 ml pack size;
• sterile, pre filled presentation;
• CaHA particles approximately 25-45 microns in size;
• no lidocaine pre-incorporated.

Radiesse 1.5ml is sold separately from a lidocaine-containing presentation. For this version, lidocaine quantity is not part of the packaged formulation and no local anesthetic is pre-mixed into the syringe.

Benefits of Radiesse

Unlike some other dermal fillers that mainly provide filling, Radiesse temporarily adds volume while the CaHA component stimulates collagen production. This supports the body’s natural production of structural proteins around the treated area and may contribute to sustained skin improvements. A Radiesse cosmetic treatment therefore combines immediate results with gradual collagen growth. Its effect is useful where volume loss accompanies deeper structural changes.

Depending on anatomy and indication, treatment may help:

• soften smile lines and marionette lines;
• improve facial contours and jaw line definition;
• reduce moderate to severe folds and deep wrinkles;
• create a firming effect where structural lift needed is identified.

The product is not simply used to correct wrinkles from the surface. Its structural behavior can be useful when stronger support is required, but the treatment area, tissue thickness, and individual anatomy still determine suitability.

Order of Application

Treatment begins with assessment of facial anatomy, medical history, previous procedures, and the planned correction. The skin is prepared before injection, while amount, depth, and technique are selected by a qualified practitioner. Radiesse should not be injected according to one fixed pattern across the face. Controlled placement is particularly important in deeper or vascularly sensitive areas.

Placement and Area Selection

For its labeled facial indication, Radiesse is placed subdermally for treating moderate to severe facial wrinkles and folds. Technique may involve tissue planes close to the deep dermis or deeper structures when appropriate for the indication and local labeling. The upper lip, radial lip lines, nose, acne scars, and other skin depressions should not automatically be considered routine targets, because some uses may be off-label or require additional risk assessment. These versatile applications depend on anatomy, training, and regional product guidance.

Who Should Not Receive Radiesse?

The product is contraindicated in people with known hypersensitivity to any of its components, bleeding disorders, or a history of severe allergies, including anaphylaxis or multiple severe allergic reactions. Treatment should also be postponed when active inflammation or infection is present in or close to the intended injection area.

Safety during pregnancy and breastfeeding has not been established, and these circumstances should be discussed before any procedure is considered. There is also limited safety information for people who are particularly prone to keloids or hypertrophic scars. A history of previous herpes outbreaks is relevant as well, since injections may be associated with reactivation in susceptible individuals.

Previous cosmetic procedures deserve attention during the initial assessment. Recent or planned laser procedures, chemical or mechanical peels, UV-based treatments, and other interventions in the same area may affect treatment planning, as combined use has not been fully evaluated in controlled clinical studies.

Duration of Effect

The gel carrier gives visible correction immediately after placement, while CaHA remains involved in the tissue response as the carrier is absorbed. Manufacturer information states that results can last up to two years, although duration varies by indication and individual factors. Most patients will not follow exactly the same retreatment schedule. Metabolism, injected volume, facial movement, and tissue quality all influence how long the treated area maintains correction.

Side Effects

Common side effects include swelling, redness, bruising, pain, itching, tenderness, and temporary contour irregularity. Blood thinners or other medications may increase the risk of bruising or bleeding at the injection site when using Radiesse, which is why current medications should be discussed with the treating healthcare professional before the procedure. Nodules, lumps, infection, or inflammatory reactions may also occur, although their frequency and severity can vary.

A serious risk of Radiesse injections is accidental injection into a blood vessel, which can cause vascular occlusion. This may lead to tissue damage and, in rare cases, serious visual or neurological complications. Unusual pain, blanching, changes in vision, or neurological symptoms during or after injection require immediate medical assessment.

Possible reactions are:

• localized swelling, redness, or bruising;
• tenderness, itching, or temporary firmness;
• palpable nodules or contour irregularity;
• vascular compromise requiring immediate intervention.

Risk depends on anatomy, injection depth, previous procedures, and technique rather than on the filler alone. Deep or technically demanding areas require particular care, and Radiesse should be administered by healthcare professionals trained in facial anatomy and the management of injection-related complications.

Aftercare Following Radiesse Treatment

The hours immediately after treatment are generally focused on allowing temporary injection-site reactions to settle without unnecessary irritation. Mild redness, swelling, tenderness, or bruising may be present, and the appearance of the area can continue to change as these reactions resolve. Patients should follow the individual instructions provided by the treating professional rather than manipulating the area or attempting to correct temporary irregularities themselves.

For approximately the first 24 hours, or until initial swelling and redness have subsided, recommended precautions may include:

• minimizing strenuous physical activity;
• avoiding extensive exposure to heat;
• limiting prolonged sun exposure;
• observing the treated area for unexpected changes.

Another detail worth noting is that calcium hydroxyapatite particles are radiopaque. They can be visible on CT imaging and may also appear on conventional X-rays, so patients should inform healthcare professionals and radiologists about previous Radiesse injections when relevant imaging is performed. This does not normally interfere with routine care, but awareness of the filler can help with interpretation of imaging findings.

Storage Conditions

Unopened Radiesse should be stored at controlled room temperature between 15°C and 32°C (59°F-90°F) and not used after its expiration date. The syringe is for single use, so opened or partially used material should not be kept for a later procedure. Packaging should remain intact until preparation for treatment. Clinics should also distinguish this product clearly from the separate lidocaine-containing presentation.

For inventory checks, confirm:

• product name and syringe volume;
• expiration date and package integrity;
• appropriate storage conditions;
• whether the ordered presentation contains lidocaine.

OGOMed lists Radiesse 1.5ml separately from its lidocaine-containing version. Friendly customer service associates can clarify pack size, supplied presentation, or shipping details, while questions about injection depth, patient suitability, and technique remain with the treating healthcare professional. This helps keep ordering information separate from clinical decision-making.

Where to Buy Radiesse 1.5ml

Availability of professional dermal fillers often depends on the supplier, product presentation, and intended clinical use. For those who need to buy Radiesse 1.5 ml, OGOMed is one of the online sources where this formulation can be purchased for professional aesthetic practice.

Radiesse 1.5ml is used for volume restoration and correction of moderate to severe facial wrinkles and folds. When sourcing the product, attention is typically given to the exact formulation, package integrity, storage conditions, and suitability for professional use.